| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 104.46× | 104.46× | 133.84× | — | 154.53× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.52× | 0.52× | 0.45× | 0.39× | 0.28× | ||
| −0.14× | −0.14× | −0.32× | 0.57× | −0.87× | ||
| −0.16× | −0.16× | −0.33× | 1.27× | −1.52× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 154.53 | — | 133.84 | 104.46 | 104.46 | |
| Asset Turnover | 0.28 | 0.39 | 0.45 | 0.52 | 0.52 | |
| Cash Conversion (CFO/Net Income) | -0.87 | 0.57 | -0.32 | -0.14 | -0.14 | |
| CFO/EBITDA | -1.52 | 1.27 | -0.33 | -0.16 | -0.16 |